QUOTE AND NEWS
Business Wire  Nov 18  Comment 
Magellan Health Services, Inc. (Nasdaq:MGLN) today announced that it will release financial guidance for 2010 on Tuesday, December 15, 2009. Chairman and Chief Executive Officer René Lerer, M.D., President Karen S. Rohan, and Chief Financial Officer
Stock Blog Hub  Nov 3  Comment 
Magellan Health Services Inc. (MGLN) reported third quarter results last Friday. The company posted a 31.9% growth in net income to $31.0 million or 88 cents per share, compared to $23.5 million or 58 cents per share in the year-ago period, and...
MarketWatch  Oct 30  Comment 
Magellan Health Services said Friday that third-quarter net income rose to $31.0 million, or 88 cents a share, from $21.9 million, or 58 cents a share, a year ago. Revenue rose to $667.6 million, from $656.5 million last year. Analysts had been...
StreetInsider.com  Oct 30  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Magellan+Health+Services+%28MGLN%29+Tops+Q3+EPS+by+24c%3B+Raises+Guidance+to+Upper+End/5059109.html for the full story.
Business Wire  Oct 30  Comment 
Magellan Health Services, Inc. (Nasdaq:MGLN) today reported net income of $31.0 million, or $.88 per diluted common share, and segment profit of $64.5 million for the third quarter of 2009. The Company also increased guidance for the full year to the
Business Wire  Oct 29  Comment 
Magellan Health Services, Inc. (Nasdaq:MGLN) announced today that members of the Company’s management team will present a general overview of the Company and discuss its business strategy at two upcoming investor conferences: Karen Rohan,
Business Wire  Sep 30  Comment 
Magellan Health Services, Inc. (Nasdaq:MGLN) today announced that it will release third quarter 2009 earnings results on Friday, October 30, 2009. Management will discuss the Company’s financial results as well as its business strategy and outlook
Business Wire  Aug 31  Comment 
Thomas Dehn, M.D., FACR, executive vice president and chief medical officer of National Imaging Associates, a Magellan Health Services (Nasdaq: MGLN) company, today issued the following statement about the New England Journal of Medicine study
StreetInsider.com  Jul 31  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Stock+Buybacks/Magellan+Health+Services+%28MGLN%29+Reports+Q2+In-Line%3B+Re-affirms%3B+May+Buyback+Up+To+%24100M/4834265.html for the full story.
MarketWatch  Jul 31  Comment 
Magellan Health Friday posted second-quarter net income of $18.4 million, or 53 cents a share, vs. $21.9 million, or 54 cents a share a year earlier. The company said revenue fell to $635.8 million from $656.9 million a year earlier. The company...
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 
 
TOP CONTRIBUTORS
MGLN AT A GLANCE
 
 
 
 
 
 
 
 

COMPANY OVERVIEW Magellan Health Solutions is a specialty managed healthcare company offering an array of management services to health plans, insurance companies, corporations, labor unions, and carious government entities comprising more than 62 million members. Services offered by the company fall broadly into three categories: (1) managed behavioral healthcare, which encompasses both commercial and public sector contracts, (2) radiology benefits management, and (3) specialty pharmaceutical management.

Magellan offers its services to health care payers on either an at-risk or ASO (administrative services only) arrangement. Under at-risk contracts, Magellan assumes responsibility for the cost of providing treatment services in exchange for a fixed monthly fee. Under ASO contracts, Magellan provides an array of support services on a fee-for-services basis, such as utilization review, claims administration, and provider network management, but does not assume responsibility for the actual cost of treatment. Magellan also offers employee assistance programs (EPSs) in which the company provides short-term counseling.

Segment Overview

Magellan offers its services to health care payers on either an at-risk or ASO (administrative services only) arrangement. Under at-risk contracts, Magellan assumes responsibility for the cost of providing treatment services in exchange for a fixed monthly fee. Under ASO contracts, Magellan provides an array of support services on a fee-for-services basis, such as utilization review, claims administration, and provider network management, but does not assume responsibility for the actual cost of treatment. Magellan also offers employee assistance programs (EPSs) in which the company provides short-term counseling.

Managed Behavioral Healthcare

Magellan’s managed behavioral healthcare business provides coordination and management of the delivery of behavioral healthcare treatment services that are contracted through the company’s network of third-party treatment provides, including psychiatrists, psychologists, psychiatric hospitals, and residential treatment centers. With the exception of 24 facilities obtained through the company’s contact with the Maricopa County Behavioral Health Authority, which are in the process of being divested, Magellan does not own or operate treatment facilities, but rather contracts with behavioral health providers at favorable reimbursement rates.

Magellan provides managed behavioral healthcare service to the customers, through the following two segments

Commercial: The segment represents the services provided under the contract with managed care companies, health insurers and other health plans, Medicaid and Medicare members, as well as with employers, including corporation and governmental agencies and labor unions.

Public Sector: The segment represents the services provided to Medicaid recipients under contract with state and local governmental agencies.

Radiology Benefits Management

Magellan entered the radiology benefits management sector in January of 2006 through the acquisition of National Imaging Associates (NIA). The company’s Radiology Benefits Management segment manages the delivery of diagnostic imaging services on behalf of health plans to ensure that usage of imaging is both clinically appropriate and cost effective.

Specialty Pharmaceutical Management

Magellan entered the Specialty Pharmaceutical Management sector in July of 2006 through the acquisition of ICORE Healthcare, LLC. Magellan’s Specialty Pharmaceutical Management segment distributes and manages high-cost drugs used in the treatment of serious, chronic medical conditions, including cancer, multiple sclerosis, hemophilia, infertility, rheumatoid arthritis, and hepatitis, among others.




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki